The Financial Regulatory Administration: Steadily develop disease insurance and support insurance companies with good regulatory ratings to carry out dividend-type long-term health insurance business

The National Financial Regulatory Administration issued guidance on promoting the high-quality development of health insurance, steadily developing disease insurance. In conjunction with changes in disease spectrum and the development of medical technology, timely revisions of disease definitions in disease insurance will be made. Regular reviews of disease incidence will be conducted, and the major disease incidence table for the life insurance industry will be updated as needed. Support will be given to insurance companies with good regulatory ratings to carry out dividend-type long-term health insurance business